Therapeutic selection for abnormal uterine bleeding with ovulatory dysfunction: a cross-sectional study in Chinese women.

IF 2.4 Q3 MEDICINE, RESEARCH & EXPERIMENTAL
Future Science OA Pub Date : 2025-12-01 Epub Date: 2025-02-07 DOI:10.1080/20565623.2025.2459001
Xiaoyue Zhao, Min Luo, Qinjie Tian
{"title":"Therapeutic selection for abnormal uterine bleeding with ovulatory dysfunction: a cross-sectional study in Chinese women.","authors":"Xiaoyue Zhao, Min Luo, Qinjie Tian","doi":"10.1080/20565623.2025.2459001","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>To investigate the therapeutic selection of abnormal uterine bleeding with ovulatory dysfunction (AUB-O) among Chinese women and analyze the impact of various factors.</p><p><strong>Methods: </strong>This was a cross-sectional study involving 3527 patients with AUB-O diagnosed by local doctor between 14 and 55 years old. Questionnaire compiled according to the Chinese AUB-O treatment guidelines was used to collect the demographic and therapeutic information.</p><p><strong>Results: </strong>The patients were divided into the juvenile group, the reproductive group, and the senior group. The results showed that irregular menstruation (37.6-46.3%), dysmenorrhea (29.9-44.4%), and heavy menstrual bleeding (16.7-32.2%) were the main symptoms in Chinese AUB-O patients. Most of the patients chose to seek help in the Department of General Gynecology (78.6-90.7%). Among the therapeutic options, combined oral contraceptives (COCs) met the treatment expectations with high acceptance among patients (36.6%-52.2%).</p><p><strong>Conclusion: </strong>This study underscores the crucial need to fortify the endocrine diagnostic proficiency of doctors within the Department of General Gynecology. Furthermore, it also indicates that implementing clinical medication education programs for patients could facilitate their correct selection of appropriate therapeutic strategies for AUB-O.</p>","PeriodicalId":12568,"journal":{"name":"Future Science OA","volume":"11 1","pages":"2459001"},"PeriodicalIF":2.4000,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11812333/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Future Science OA","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1080/20565623.2025.2459001","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/2/7 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: To investigate the therapeutic selection of abnormal uterine bleeding with ovulatory dysfunction (AUB-O) among Chinese women and analyze the impact of various factors.

Methods: This was a cross-sectional study involving 3527 patients with AUB-O diagnosed by local doctor between 14 and 55 years old. Questionnaire compiled according to the Chinese AUB-O treatment guidelines was used to collect the demographic and therapeutic information.

Results: The patients were divided into the juvenile group, the reproductive group, and the senior group. The results showed that irregular menstruation (37.6-46.3%), dysmenorrhea (29.9-44.4%), and heavy menstrual bleeding (16.7-32.2%) were the main symptoms in Chinese AUB-O patients. Most of the patients chose to seek help in the Department of General Gynecology (78.6-90.7%). Among the therapeutic options, combined oral contraceptives (COCs) met the treatment expectations with high acceptance among patients (36.6%-52.2%).

Conclusion: This study underscores the crucial need to fortify the endocrine diagnostic proficiency of doctors within the Department of General Gynecology. Furthermore, it also indicates that implementing clinical medication education programs for patients could facilitate their correct selection of appropriate therapeutic strategies for AUB-O.

求助全文
约1分钟内获得全文 求助全文
来源期刊
Future Science OA
Future Science OA MEDICINE, RESEARCH & EXPERIMENTAL-
CiteScore
5.00
自引率
4.00%
发文量
48
审稿时长
13 weeks
期刊介绍: Future Science OA is an online, open access, peer-reviewed title from the Future Science Group. The journal covers research and discussion related to advances in biotechnology, medicine and health. The journal embraces the importance of publishing all good-quality research with the potential to further the progress of research in these fields. All original research articles will be considered that are within the journal''s scope, and have been conducted with scientific rigour and research integrity. The journal also features review articles, editorials and perspectives, providing readers with a leading source of commentary and analysis. Submissions of the following article types will be considered: -Research articles -Preliminary communications -Short communications -Methodologies -Trial design articles -Trial results (including early-phase and negative studies) -Reviews -Perspectives -Commentaries
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信